Memorial Sloan-Kettering's multidisciplinary team of nearly 30 physicians with expertise in pancreatic cancer and pancreatic cysts is one of the largest and busiest in the nation, treating more than 800 patients annually. Our surgeons, experts in open as well as minimally invasive approaches, perform more than 300 pancreatic cancer procedures each year. Recent developments in chemotherapy combinations have aided in slowing disease advancement in many patients.
Our nomogram, based on such factors as margin of resection and location of lesion, is commonly used to define and predict treatment outcome in adults with resected adenocarcinoma of the pancreas.
Memorial Sloan-Kettering radiation oncologists are simultaneously pioneering new techniques to treat the disease and enhance quality-of-life measures. As lead investigators in multiple clinical trials, we are equipped to provide many of our patients with access to innovative diagnostic approaches and new treatments.